Sort by
Refine Your Search
-
Position Details Position Information Recruitment/Posting Title Post Doctoral Associate - Rail Department Advanced Infrastructure Center Salary Details Minimum Salary $63,968 Offer Information
-
Associate will conduct genetic, microbiological, biochemical and animal studies to identify compounds that inhibit or kill Mycobacterium tuberculosis and to better understand their targets and mechanisms
-
-targeting by ATPase enzymes in ribosome biogenesis. The main project involves studying the mechanisms of pre-ribosome maturation by motor proteins, an essential process for generating new ribosomes
-
for setting up experimental systems to study type VI CRISPR-Cas defense mechanisms and analyzing collateral RNA damage using RNA-sequencing. KEY DUTIES: 60 % 1. Conduct research on RNA-targeting type VI CRISPR
-
in programming (MATLAB, Python, R) Experience using advanced statistics Ability to build advanced experimental interfaces (using Matlab, Psychopy, JavaScript, etc.) Track record in publishing
-
neuroscience, or neural decoding. Experience with multimodal data integration (EEG + imaging/behavior). Track record of peer-reviewed publications. Interest in developing an independent research program
-
., Alzheimer’s or Parkinson’s) and a track record of first author publications, a plus. Experience with the development and validation of advanced cellular models, such as induced pluripotent stem cell–derived
-
, mouse handling, preferred. Track record of scientific productivity, including at least one first-author publication or preprint, preferred. Experience with mouse surgery, CRISPR-based gene manipulation in
-
, JavaScript, etc.) Track record in publishing scientific articles Certifications/Licenses Required Knowledge, Skills, and Abilities Preferred Qualifications Preferred Qualifications Prior experience conducting
-
the Department of Medicinal Chemistry on or about November 3, 2025. The successful candidates will participate in NIH-funded research projects in designing and developing small molecule antivirals targeting